10 Years Follow-up Study of Plantar Pressure, Kinetics and Kinematics in a Cohort of Patients Diagnosed With Diabetes (Diab10)

May 4, 2022 updated by: Ulla Hellstrand Tang, Sahlgrenska University Hospital, Sweden

10 Years Follow-up of Gait Characteristics, Plantar Pressure, Kinetics and Kinematics in a Cohort of Patients Diagnosed With Diabetes

A combination of diabetes and neuropathy can cause an altered gait, increased tissue stiffness, limited joint mobility, muscle weakness, foot deformities, thus leading to excessive plantar pressure. The presence of an increased plantar pressure and the loss of sensation is a serious risk factor in the risk of development of diabetic foot ulcers (DFU). Therefore, appropriate shoes and insoles are recommended to redistribute high peak pressure (PP) and reduce pressure time integral (PTI) . Shoe modifications and insoles, when used, is effective to prevent the recurrence of plantar ulcer.

The primary aim of the study was to: explore gait characteristics, kinetics and kinematics in a cohort of patients diagnosed with diabetes, with and without neuropathy, assigned to use different types of insoles. The second aim was to assess the relation between gait characteristics, kinetics and kinematics to high plantar PP and PTI. The third aim was to compare gait characteristics, kinetics and kinematics of patients with diabetes and healthy controls.

Study Overview

Detailed Description

A combination of diabetes and neuropathy can cause an altered gait, increased tissue stiffness, limited joint mobility, muscle weakness, foot deformities, thus leading to excessive plantar pressure . The presence of an increased plantar pressure and the loss of sensation is a serious risk factor in the risk of development of diabetic foot ulcers (DFU). Therefore, appropriate shoes and insoles are recommended to redistribute high peak pressure (PP) and reduce pressure time integral (PTI). Shoe modifications and insoles, when used, is effective to prevent the recurrence of plantar ulcer.

Patients presenting with mild or absence of neuropathy have lower PP compared to those having more severe stages of neuropathy. However, these findings are not unambiguous. In a study patients walked in a standardize speed of 1.2 m/s, and it was only under the first metatarsal phalangeal joint that the group with neuropathy had higher PP compared to patients with diabetes without neuropathy. In the remaining parts of the foot sole, there was no difference. In a study comparing custom-made insoles and prefabricated insoles used in a walking shoe, a cohort of patients with no history of foot ulcers was studied and there were no differences in PP for the sub groups with and without neuropathy.

More knowledge is needed regarding risk factors such as neuropathy, gait deviation and differences in kinematics and kinetics in order to prevent the onset of the "first" plantar ulcer.

Study Type

Interventional

Enrollment (Actual)

224

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Region Västragötaland
      • Gothenburg, Region Västragötaland, Sweden, 41285
        • Department of Prostetics & Orthotics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Intervention groups:

  • To be a participant in the original RCT
  • To be aged 18 years or more
  • To walk without walking aid
  • To understand the Swedish language
  • No presence of foot ulcer

Exclusion Criteria:

  • Presence of foot ulcers

Control group

  • To be first-time visitors to the DPO
  • To be aged 18 years or more
  • To walk without walking aid
  • To understand the Swedish language
  • No presence of foot ulcer

Exclusion Criteria:

  • Presence of foot ulcers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prefabricated insoles
Prefabricated insoles with support in medial arch and metatarsal pad. A 2 mm top layer of cushioned material.
The participants received prefabricated insoles
Experimental: Custom-made insoles soft
Custom-made insoles formed over an individual cast positive. 35 shore of hardness in material Ethyl Vinyl Acetate.
The participants received soft custom-made insoles
Experimental: Custom-made hard
Custom-made insoles formed over an individual cast positive. 55 shore of hardness in material Ethyl Vinyl Acetate.
The participants received hard custom-made insoles
No Intervention: Control group
No intervention with therapeutic insoles and/or shoes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak pressure
Time Frame: through study completion, an average of 1 year
To compare the differences of peak pressure (kPa) in the four groups.
through study completion, an average of 1 year
Pressure time integral
Time Frame: through study completion, an average of 1 year
To compare the differences of pressure time integral (kPa*s) in the four groups.
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Moment at ankle-knee-and hip joint
Time Frame: through study completion, an average of 1 year
To compare the differences of joint moment (Nm/kg) in the four groups.
through study completion, an average of 1 year
Speed
Time Frame: through study completion, an average of 1 year
To compare the differences of speed (m/s) in the four groups.
through study completion, an average of 1 year
Cadence
Time Frame: through study completion, an average of 1 year
To compare the differences of cadence (step/min) in the four groups.
through study completion, an average of 1 year
Stance (percent of stand phase)
Time Frame: through study completion, an average of 1 year
To compare the differences of stance phase (%) in the four groups.
through study completion, an average of 1 year
Range of foot-knee and hip angles (minimum to maximum)
Time Frame: through study completion, an average of 1 year
To compare the differences of maximum angle (degree) in the four groups
through study completion, an average of 1 year
Walking distance of 5 minutes walking
Time Frame: through study completion, an average of 1 year
To compare the differences of 5 minutes walking(m) distance in the four groups
through study completion, an average of 1 year
Distribution of risk grade ( the risk to develop diabetic foot ulcers 1-4(1=no risk, 4=presence of foot ulcers)
Time Frame: through study completion, an average of 1 year
To assess the distribution of risk grade (1-4) in the four groups
through study completion, an average of 1 year
Relation of different types of insoles and risk factors to peak pressure
Time Frame: through study completion, an average of 1 year
To assess the influence of different types of insoles and risk factors on high peak pressure (kPa)
through study completion, an average of 1 year
Relation of different types of insoles and risk factors to pressure time integral
Time Frame: through study completion, an average of 1 year
To assess the influence of different types of insoles and risk factors on pressure time integral (kPa*s)
through study completion, an average of 1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health related quality of life
Time Frame: through study completion, an average of 1 year
To assess the quality of life (SF-36 and EQ-5D-5L) in the different groups
through study completion, an average of 1 year
Costs for the assistive devices
Time Frame: through study completion, an average of 1 year
Calculation of costs (SEK and USD) for the assistive devices
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Björn Stålgren, BSc, Sahlgrenska University Hospital, Sweden

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

January 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

July 25, 2019

First Submitted That Met QC Criteria

August 10, 2019

First Posted (Actual)

August 13, 2019

Study Record Updates

Last Update Posted (Actual)

May 5, 2022

Last Update Submitted That Met QC Criteria

May 4, 2022

Last Verified

May 1, 2022

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Clinical Trials on Prefabricated insoles

3
Subscribe